Oxadiazole transient receptor potential channel inhibitors
US10710994B2 · kind B2 · utility
1Cited by
8References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 15, 2019 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Mar 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.